Monash IVF Group Limited (ASX:MVF)
Australia · Delayed Price · Currency is AUD 0.6850
-0.0150 (-2.14%)
Aug 7, 2026, 4:10 PM AEST
Monash IVF Group Market Cap
Monash IVF Group has a market cap or net worth of 266.9 million as of August 7, 2026. Its market cap has decreased by -15.43% in one year.
Market Cap
266.90M
Enterprise Value
460.49M
Revenue
269.39M
Ranking
n/a
PE Ratio
17.63
Stock Price
0.69
ChartMarket Cap Chart
Since June 26, 2014, Monash IVF Group's market cap has decreased from 534.53M to 266.90M, a decrease of -50.07%. That is a compound annual growth rate of -5.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 266.90M | -6.80% |
| Dec 31, 2025 | 286.38M | -42.13% |
| Dec 31, 2024 | 494.84M | -2.31% |
| Dec 29, 2023 | 506.53M | 36.13% |
| Dec 30, 2022 | 372.10M | -9.48% |
| Dec 31, 2021 | 411.06M | 34.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 826.92M |
| Australian Clinical Labs | 441.54M |
| Healius | 297.72M |
| Cryosite | 58.57M |
| Microba Life Sciences | 33.70M |
| INOVIQ | 28.16M |
| Rhythm Biosciences | 27.42M |
| BCAL Diagnostics | 23.96M |